Table of Contents
ISRN Nursing
Volume 2011, Article ID 672579, 6 pages
http://dx.doi.org/10.5402/2011/672579
Review Article

Genomics and Pain Research in Sickle Cell Disease: An Explanation of Heterogeneity?

College of Nursing, University of Texas at Arlington, 411 S. Nedderman Drive, Arlington, TX 76019, USA

Received 8 March 2011; Accepted 24 March 2011

Academic Editors: S. McClement and R. Northway

Copyright © 2011 Maxine Adegbola. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. S. Mogil and M. Devor, “Introduction to pain genetics,” in The Genetics of Pain: Progress in Pain Research and Management, J. Mogil, Ed., International Association for the Study of Pain, Seattle, Wash, USA, 2004. View at Google Scholar
  2. J. S. Mogil and M. Devor, “Introduction to pain genetics,” in The Genetics of Pain, J. S. Mogil, Ed., pp. 1–17, IASP, Baltimore, Md, USA, 2004. View at Google Scholar
  3. R. R. Edwards, “Individual differences in endogenous pain modulation as a risk factor for chronic pain,” Neurology, vol. 65, no. 3, pp. 437–443, 2005. View at Publisher · View at Google Scholar · View at Scopus
  4. L. Diatchenko, G. D. Slade, A. G. Nackley et al., “Genetic basis for individual variations in pain perception and the development of a chronic pain condition,” Human Molecular Genetics, vol. 14, no. 1, pp. 135–143, 2005. View at Publisher · View at Google Scholar · View at Scopus
  5. U. M. Stamer and F. Stüber, “Genetic factors in pain and its treatment,” Current Opinion in Anaesthesiology, vol. 20, no. 5, pp. 478–484, 2007. View at Publisher · View at Google Scholar · View at Scopus
  6. I. Tegeder and J. Lötsch, “Current evidence for a modulation of low back pain by human genetic variants,” Journal of Cellular and Molecular Medicine, vol. 13, no. 8B, pp. 1605–1619, 2009. View at Publisher · View at Google Scholar · View at Scopus
  7. B. Oertel and J. Lötsch, “Genetic mutations that prevent pain: implications for future pain medication,” Pharmacogenomics, vol. 9, no. 2, pp. 179–194, 2008. View at Publisher · View at Google Scholar · View at Scopus
  8. H. F. Bunn, “Pathogenesis and treatment of sickle cell disease,” The New England Journal of Medicine, vol. 337, no. 11, pp. 762–769, 1997. View at Publisher · View at Google Scholar · View at Scopus
  9. M. H. Steinberg, “Management of sickle cell disease,” The New England Journal of Medicine, vol. 340, no. 13, pp. 1021–1030, 1999. View at Publisher · View at Google Scholar · View at Scopus
  10. Center for Disease Control (CDC), “Sickle cell disease data and statistics,” 2010, http://www.cdc.gov/NCBDDD/sicklecell/data.html.
  11. National Heart Lung and Blood Institute (NHLBI), 2011, http://www.nhlbi.nih.gov/health/dci/Diseases/Sca/SCA_WhoIsAtRisk.html.
  12. D. J. Weatherall and J. B. Clegg, “Inherited haemoglobin disorders: an increasing global health problem,” Bulletin of the World Health Organization, vol. 79, no. 8, pp. 704–712, 2001. View at Google Scholar · View at Scopus
  13. Genetics Home Reference, “US National Library of Medicine,” 2011, http://ghr.nlm.nih.gov/condition/sickle-cell-disease.
  14. K. A. Anie, F. E. Egunjobi, and O. O. Akinyanju, “Psychosocial impact of sickle cell disorder: perspectives from a Nigerian setting,” Globalization and Health, vol. 6, article 2, 2010. View at Publisher · View at Google Scholar · View at Scopus
  15. I. Roberts and M. de Montalembert, “Sickle cell disease as a paradigm of immigration hematology: new challenges for hematologists in Europe,” Haematologica, vol. 92, no. 7, pp. 865–871, 2007. View at Publisher · View at Google Scholar · View at Scopus
  16. World Health Organization (WHO), “Sickle-cell disease and other haemoglobin disorders,” 2011, http://www.who.int/mediacentre/factsheets/fs308/en/index.html.
  17. F. Tennant, “Brain atrophy with chronic pain: a call to enhanced treatment,” Practical Pain Management, March 2009.
  18. N. Torrance, A. M. Elliott, A. J. Lee, and B. H. Smith, “Severe chronic pain is associated with increased 10 year mortality. A cohort record linkage study,” European Journal of Pain, vol. 14, no. 4, pp. 380–386, 2010. View at Publisher · View at Google Scholar · View at Scopus
  19. G. McHugh and G. Thoms, “Living with chronic pain: the patient's perspective,” Nursing Standard, vol. 15, no. 52, pp. 33–37, 2001. View at Google Scholar · View at Scopus
  20. K. H. Todd, C. Green, V. L. Bonham Jr., C. Haywood, and E. Ivy, “Sickle cell disease related pain: crisis and conflict,” Journal of Pain, vol. 7, no. 7, pp. 453–458, 2006. View at Publisher · View at Google Scholar · View at Scopus
  21. A. K. Geller and M. K. O'Connor, “The sickle cell crisis: a dilemma in pain relief,” Mayo Clinic Proceedings, vol. 83, no. 3, pp. 320–323, 2008. View at Publisher · View at Google Scholar · View at Scopus
  22. R. J. Gatchel, “Comorbidity of chronic pain and mental health disorders: the biopsychosocial perspective,” American Psychologist, vol. 59, no. 8, pp. 795–805, 2004. View at Publisher · View at Google Scholar · View at Scopus
  23. J. Dersh, P. B. Polatin, and R. J. Gatchel, “Chronic pain and psychopathology: research findings and theoretical considerations,” Psychosomatic Medicine, vol. 64, no. 5, pp. 773–786, 2002. View at Publisher · View at Google Scholar · View at Scopus
  24. V. J. Thomas, R. Gruen, and S. Shu, “Cognitive-behavioural therapy for the management of sickle cell disease pain: identification and assessment of costs,” Ethnicity and Health, vol. 6, no. 1, pp. 59–67, 2001. View at Publisher · View at Google Scholar · View at Scopus
  25. K. A. Anie and J. Green, “Psychological therapies for sickle cell disease and pain,” Cochrane Database of Systematic Reviews, no. 1, 2006. View at Google Scholar
  26. K. A. Anie, A. Steptoe, and D. H. Bevan, “Sickle cell disease: pain, coping and quality of life in a study of adults in the UK,” British Journal of Health Psychology, vol. 7, no. 3, pp. 331–344, 2002. View at Publisher · View at Google Scholar · View at Scopus
  27. C. L. Edwards, M. T. Scales, C. Loughlin et al., “A brief review of the pathophysiology, associated pain, and psychosocial issues in sickle cell disease,” International Journal of Behavioral Medicine, vol. 12, no. 3, pp. 171–179, 2005. View at Publisher · View at Google Scholar · View at Scopus
  28. P. J. Nietert, M. D. Silverstein, and M. R. Abboud, “Sickle cell anaemia: epidemiology and cost of illness,” PharmacoEconomics, vol. 20, no. 6, pp. 357–366, 2002. View at Google Scholar · View at Scopus
  29. IASP, “International Association for the study of pain,” IASP, supplement 3, pp. S1–S225, 1986. View at Google Scholar
  30. L. J. Benjamin, C. Dampier, A. Jacox et al., Eds., Guideline for the Management of Acute and Chronic Pain in Sickle-Cell Disease, APS Clinical Guidelines Series, no. 1, American Pain Society, Glenview, Ill, USA, 1999.
  31. K. H. Todd, “Chronic pain and aberrant drug-related behavior in the emergency department,” Journal of Law, Medicine and Ethics, vol. 33, no. 4, pp. 761–769, 2005. View at Publisher · View at Google Scholar · View at Scopus
  32. S. Bergman, “Psychosocial aspects of chronic widespread pain and fibromyalgia,” Disability and Rehabilitation, vol. 27, no. 12, pp. 675–683, 2005. View at Publisher · View at Google Scholar · View at Scopus
  33. R. J. Dunlop and K. C. Bennett, “Pain management for sickle cell disease,” Cochrane Database of Systematic Reviews, no. 2, Article ID CD003350, 2006. View at Google Scholar · View at Scopus
  34. L. E. V. Taylor, N. A. Stotts, J. Humphreys, M. J. Treadwell, and C. Miaskowski, “A review of the literature on the multiple dimensions of chronic pain in adults with sickle cell disease,” Journal of Pain and Symptom Management, vol. 40, no. 3, pp. 416–435, 2010. View at Google Scholar
  35. S. Schubert, “Sickle cell patients find pain relief: new home treatment model reduces hospital emergency visits, inpatient days,” Infusion, vol. 11, no. 1, p. 23, 2005. View at Google Scholar
  36. S. K. Ballas, “Sickle cell anaemia: progress in pathogenesis and treatment,” Drugs, vol. 62, no. 8, pp. 1143–1172, 2002. View at Google Scholar · View at Scopus
  37. C. R. Green, K. O. Anderson, T. A. Baker et al., “The unequal burden of pain: confronting racial and ethnic disparities in pain,” Pain Medicine, vol. 4, no. 3, pp. 277–294, 2003. View at Google Scholar
  38. C. R. Green, K. O. Anderson, T. A. Baker et al., “Erratum in : The unequal burden of pain: confronting racial and ethnic disparities in pain,” Pain Medicine, vol. 6, no. 1, p. 99, 2005. View at Google Scholar
  39. I. P. Aisiku, W. R. Smith, D. K. McClish et al., “Comparisons of high versus low emergency department utilizers in sickle cell disease,” Annals of Emergency Medicine, vol. 53, no. 5, pp. 587–593, 2009. View at Publisher · View at Google Scholar · View at Scopus
  40. P. Newcombe, “Pathophysiology of sickle cell disease crisis,” Emergency Nurse, vol. 9, no. 9, pp. 19–22, 2002. View at Google Scholar · View at Scopus
  41. D. K. McClish, L. T. Penberthy, V. E. Bovbjerg et al., “Health related quality of life in sickle cell patients: the PiSCES project,” Health and Quality of Life Outcomes, vol. 3, article 50, 2005. View at Publisher · View at Google Scholar · View at Scopus
  42. W. R. Smith, L. T. Penberthy, V. E. Bovbjerg et al., “Daily assessment of pain in adults with sickle cell disease,” Annals of Internal Medicine, vol. 148, no. 2, pp. 94–101, 2008. View at Google Scholar · View at Scopus
  43. B. St. Marie and S. Arnold, When Your Pain Flares Up: Easy, Proven Techniques for Managing Chronic Pain, Fairview Press, Minneapolis, Minn, USA, 2002.
  44. M. A. Adegbola, “Lived experience of sickle cell disease pain,” in press.
  45. M. B. Max and W. F. Stewart, “The molecular epidemiology of pain: a new discipline for drug discovery,” Nature Reviews Drug Discovery, vol. 7, no. 8, pp. 647–658, 2008. View at Publisher · View at Google Scholar · View at Scopus
  46. R. R. Edwards, “Genetic predictors of acute and chronic pain,” Current Rheumatology Reports, vol. 8, no. 6, pp. 411–417, 2006. View at Publisher · View at Google Scholar · View at Scopus
  47. R. R. Edwards, M. Moric, B. Husfeldt, A. Buvanendran, and O. Ivankovich, “Ethnic similarities and differences in the chronic pain experience: a comparison of African American, Hispanic, and white patients,” Pain Medicine, vol. 6, no. 1, pp. 88–98, 2005. View at Publisher · View at Google Scholar · View at Scopus
  48. T. J. Jorgensen, I. Ruczinski, B. Kessing, M. W. Smith, Y. Y. Shugart, and A. J. Alberg, “Hypothesis-driven candidate gene association studies: practical design and analytical considerations,” American Journal of Epidemiology, vol. 170, no. 8, pp. 986–993, 2009. View at Publisher · View at Google Scholar · View at Scopus
  49. M. A. Adegbola, “Can heterogeneity of chronic sickle-cell disease pain be explained by genomics? A literature review,” Biological Research for Nursing, vol. 11, no. 1, pp. 81–97, 2009. View at Publisher · View at Google Scholar · View at Scopus
  50. C. M. Campbell, R. R. Edwards, C. Carmona et al., “Polymorphisms in the GTP cyclohydrolase gene (GCH1) are associated with ratings of capsaicin pain,” Pain, vol. 141, no. 1-2, pp. 114–118, 2009. View at Publisher · View at Google Scholar · View at Scopus
  51. I. Tegeder, J. Adolph, H. Schmidt, C. J. Woolf, G. Geisslinger, and J. Lötsch, “Reduced hyperalgesia in homozygous carriers of a GTP cyclohydrolase 1 haplotype,” European Journal of Pain, vol. 12, no. 8, pp. 1069–1077, 2008. View at Publisher · View at Google Scholar · View at Scopus
  52. I. Tegeder, M. Costigan, R. S. Griffin et al., “GTP cyclohydrolase and tetrahydrobiopterin regulate pain sensitivity and persistence,” Nature Medicine, vol. 12, no. 11, pp. 1269–1277, 2006. View at Publisher · View at Google Scholar · View at Scopus
  53. J. Lötsch, G. Geisslinger, and I. Tegeder, “Genetic modulation of the pharmacological treatment of pain,” Pharmacology and Therapeutics, vol. 124, no. 2, pp. 168–184, 2009. View at Publisher · View at Google Scholar · View at Scopus
  54. A. Doehring, C. Antoniades, K. M. Channon, I. Tegeder, and J. Lötsch, “Clinical genetics of functionally mild non-coding GTP cyclohydrolase 1 (GCH1) polymorphisms modulating pain and cardiovascular risk,” Mutation Research, vol. 659, no. 3, pp. 195–201, 2008. View at Publisher · View at Google Scholar · View at Scopus
  55. A. Doehring, R. Freynhagen, N. Griessinger et al., “Cross-sectional assessment of the consequences of a GTP cyclohydrolase 1 haplotype for specialized tertiary outpatient pain care,” Clinical Journal of Pain, vol. 25, no. 9, pp. 781–785, 2009. View at Publisher · View at Google Scholar · View at Scopus
  56. SNPedia, “Glossary,” 2011, http://www.snpedia.com/index.php/Glossary.
  57. J. Lötsch, I. Belfer, A. Kirchhof et al., “Reliable screening for a pain-protective haplotype in the GTP cyclohydrolase 1 gene (GCH1) through the use of 3 or fewer single nucleotide polymorphisms,” Clinical Chemistry, vol. 53, no. 6, pp. 1010–1015, 2007. View at Publisher · View at Google Scholar · View at Scopus
  58. J. Lötsch, P. Klepstad, A. Doehring, and O. Dale, “A GTP cyclohydrolase 1 genetic variant delays cancer pain,” Pain, vol. 148, no. 1, pp. 103–106, 2010. View at Publisher · View at Google Scholar · View at Scopus
  59. M. Lazarev, J. Lamb, M. M. Barmada et al., “Does the pain-protective GTP cyclohydrolase haplotype significantly alter the pattern or severity of pain in humans with chronic pancreatitis?” Molecular Pain, vol. 4, article 58, 2008. View at Publisher · View at Google Scholar · View at Scopus
  60. H. Kim and R. A. Dionne, “Lack of influence of GTP cyclohydrolase gene (GCH1) variations on pain sensitivity in humans,” Molecular Pain, vol. 3, article 6, 2007. View at Publisher · View at Google Scholar · View at Scopus